Sign in
4

Changes in Ownership

Armata Pharmaceuticals, Inc. Filed Acc 0001104659-26-026588

Options or other derivatives

  • Chief Business Officer acquired 183,142 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kyme Pierre Chief Business Officer 2026-03-09 Grant or award · Stock Options (Right to Buy) +183,142 183,142 D
Loading xslF345X05/tm268588-9_4seq1.xml…